Seth Karol, MD
St. Jude Children's Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Seth Karol, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:12 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06533748 · Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaSt. Jude Children's Research Hospital · recruiting · Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma · principal investigator
- Ph3NCT05183035 · Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)PedAL BCU, LLC · active not recruiting · Acute Myeloid Leukemia · principal investigator
- Ph1NCT04898894 · Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaSt. Jude Children's Research Hospital · active not recruiting · Acute Leukemia of Ambiguous Lineage in Relapse, Acute Myeloid Leukemia, in Relapse, Refractory Acute Leukemia of Ambiguous Lineage · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.